Literature DB >> 16785989

Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice.

H Tsumura1, T Yoshida, H Saito, K Imanaka-Yoshida, N Suzuki.   

Abstract

Human rhabdomyosarcomas (RMSs) frequently demonstrate genetic alterations in ras and p53. To investigate their possible involvement in the tumorigenesis, we generated a knock-in mouse line with oncogenic K-ras, conditionally expressed by Cre/LoxP system on a background of p53 alteration. Electroporation of Cre expression vector in skeletal muscle tissues resulted in the generation of tumor in adults with tumor incidences of 100% at 10 weeks and 40% at 15 weeks, in p53(-/-) and p53(-/+) backgrounds, respectively. The tumor histology was pleomorphic RMS with characteristic bizarre giant cells, positive for desmin and alpha-sarcomeric actin and exhibiting remarkable increase in total and phosphorylated extracellular signal-regulated protein kinase (ERK)1 and ERK2. Loss of the wild-type p53 was detected in K-rasG12V-expressed tumors of p53(-/+) mice. Early lesions 3 weeks after electroporation consisted of proliferating populations of myogenic progenitors, including stem cells positive for ScaI antigen, immature cells positive for desmin and neural cell adhesion molecule-positive myotubes. Thus, cooperation of oncogenic K-ras and p53 deficiency resulted in the development of pleomorphic RMS in adult mice, providing a useful mouse model for further detailed studies.

Entities:  

Mesh:

Year:  2006        PMID: 16785989     DOI: 10.1038/sj.onc.1209749

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

Review 1.  Modeling sarcomagenesis using multipotent mesenchymal stem cells.

Authors:  Rene Rodriguez; Ruth Rubio; Pablo Menendez
Journal:  Cell Res       Date:  2011-09-20       Impact factor: 25.617

Review 2.  Advances in pediatric rhabdomyosarcoma characterization and disease model development.

Authors:  D O'Brien; A G Jacob; S J Qualman; D S Chandler
Journal:  Histol Histopathol       Date:  2012-01       Impact factor: 2.303

3.  Zebrafish models of rhabdomyosarcoma.

Authors:  Eleanor Y Chen; David M Langenau
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

Review 4.  The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.

Authors:  Jilong Yang; Zhiwu Ren; Xiaoling Du; Mengze Hao; Wenya Zhou
Journal:  Stem Cell Investig       Date:  2014-10-27

Review 5.  Developmental origins of fusion-negative rhabdomyosarcomas.

Authors:  Ken Kikuchi; Brian P Rubin; Charles Keller
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

6.  Induction of a regenerative microenvironment in skeletal muscle is sufficient to induce embryonal rhabdomyosarcoma in p53-deficient mice.

Authors:  Marybeth Camboni; Sue Hammond; Laura T Martin; Paul T Martin
Journal:  J Pathol       Date:  2011-10-18       Impact factor: 7.996

7.  Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells.

Authors:  Simone Hettmer; Jianing Liu; Christine M Miller; Melissa C Lindsay; Cynthia A Sparks; David A Guertin; Roderick T Bronson; David M Langenau; Amy J Wagers
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-30       Impact factor: 11.205

8.  Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.

Authors:  Karen Fernandez; Yelda Serinagaoglu; Sue Hammond; Laura T Martin; Paul T Martin
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

9.  Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis.

Authors:  A Bigi; E Beltrami; M Trinei; M Stendardo; P G Pelicci; M Giorgio
Journal:  Oncogene       Date:  2016-03-14       Impact factor: 9.867

10.  Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells.

Authors:  Jordan M Blum; Leonor Añó; Zhizhong Li; David Van Mater; Brian D Bennett; Mohit Sachdeva; Irina Lagutina; Minsi Zhang; Jeffrey K Mito; Leslie G Dodd; Diana M Cardona; Rebecca D Dodd; Nerissa Williams; Yan Ma; Christoph Lepper; Corinne M Linardic; Sayan Mukherjee; Gerard C Grosveld; Chen-Ming Fan; David G Kirsch
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.